Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|6|705-716

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.6, 2009-09, pp. : 705-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Chaperones as Rational Drug Targets for Parkinson's Disease Therapeutics

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-01 ,pp. : 741-753

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular and Molecular Surrogate Markers to Monitor Targeted and Non- Targeted Antiangiogenic Drug Activity and Determine Optimal Biologic Dose

By  

Current Cancer Drug Targets, Vol. 5, Iss. 7, 2005-11 ,pp. : 551-559

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Cardiac Molecular Imaging Using Positron Emission Tomography in Evaluation of Drug and Therapeutics for Cardiovascular Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 7, 2005-03 ,pp. : 903-932

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

By Hoffman E.P.   Dressman D.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 9, 2001-09 ,pp. : 465-470

Elsevier

Access to resources Recommend Favorite

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 855-867

Bentham Science Publishers

Access to resources Recommend Favorite